UCLE — US Nuclear Income Statement
0.000.00%
- $0.67m
- $2.54m
- $2.23m
- 36
- 61
- 13
- 29
Annual income statement for US Nuclear, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.54 | 1.75 | 2.14 | 2.09 | 2.23 |
Cost of Revenue | |||||
Gross Profit | 1.93 | 0.475 | 1.38 | 0.788 | 0.924 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.51 | 3.84 | 3.17 | 3.59 | 3.95 |
Operating Profit | -2.97 | -2.08 | -1.03 | -1.5 | -1.72 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.16 | -3.54 | -1.88 | -2.04 | -3.43 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.16 | -3.54 | -1.88 | -2.04 | -3.43 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.16 | -3.54 | -1.88 | -2.04 | -3.43 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.16 | -3.54 | -1.93 | -2.06 | -3.44 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.145 | -0.16 | -0.083 | -0.07 | -0.093 |